relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces Pricing of Public Offering of Common Stock
25. Februar 2015 22:50 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,900,000 shares of...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces Proposed Public Offering of Common Stock
24. Februar 2015 16:01 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of up to...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
24. Februar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on February 17, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa to Present at 35th Annual Cowen and Company Healthcare Conference
23. Februar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the Cowen and Company...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
04. Februar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on February 2, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa to Present at 17th Annual BIO CEO & Investor Conference
02. Februar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 17th Annual BIO CEO...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces Helen Torley, M.B. Ch.B., M.R.C.P. Joins Board of Directors
22. Januar 2015 16:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that Helen Torley, M.B. Ch.B., M.R.C.P., has been appointed to the company's board of directors,...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
20. Januar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on January 15, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
09. Januar 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Jan. 9, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on January 2, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension
05. Januar 2015 08:00 ET | Relypsa, Inc.
FDA Not Currently Planning to Hold an Advisory Committee Meeting Company to Host Webcasted Analyst Day in New York on January 8, 2015 REDWOOD CITY, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) --...